WHO ICTRP trial

Clinical research Study to find out if the study drug INCB059872 is safe and…

EUCTR2018-000062-11-ES · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2018-000062-11-ES
Public title Clinical research Study to find out if the study drug INCB059872 is safe and effective in people who have Ewing sarcoma
Scientific title An Open-Label Phase 1b Study of the Safety, Tolerability, and Preliminary Antitumor Activity of INCB059872 in Participants With Relapsed or Refractory Ewing Sarcoma
Primary sponsor Incyte Corporation
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no
Countries United States;Spain;United Kingdom;Italy
Conditions Relapsed or Refractory Ewing Sarcoma MedDRA version: 20.0 Level: PT Classification code 10015560 Term: Ewing's sarcoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area…
Interventions Product Code: INCB059872 Pharmaceutical Form: Tablet INN or Proposed INN: Not yet available CAS Number: 1802909-49-4 Other descriptive name: INCB059872 Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 1-
Registration date Jul 8, 2018
Target size 21
Secondary IDs INCB59872-103;NCT03514407;2018-000062-11-GB
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations